ARIAD Pharmaceuticals IncNASDAQ:ARIA

Help
Symbol Lookup
    No Matches were found for
    Additional matches for ...
     
    Go
    OverviewChartsNewsFundamentalsEarningsReportsCalendarOptionsTechnical Insight

    Symbol Lookup

    Close

    Search Criteria

    Name or Symbol

    Security Type

    Fund Categories

    Market

    Expiration Filter

    Chain Type

    Submit
    Wednesday May 22, 2013 5:27 AM ET. Data delayed 15 minutes.
    17.53
    0.00 (0.00%)
    Price HistoryRefresh
    Bid/Lots
    17.52/0
    Ask/Lots
    18.98/1
    Open/Prev Close
    0.00/17.53
    Day Range
    -----
    52-Week Range
    15.13-25.40
    Vol/Avg Daily Vol
    0.0/3.7M

    ARIA Article

    Go

    May 17, 2013

    OPTIONS: Option Implied Volatility Mixed into 2013 Annual Meeting of American Society of Clinical Oncology (ASCO) 5/31-6/4
    8:41AM ET on Friday May 17, 2013 by Midnight Trader
    Companies Mentioned: GILD, INCY, MDVN, ONXX, PCYC, AMGN, ARIA, ABBV, AZN, BMRN, ROSG, CELG, DNDN
    08:41 AM EDT, 05/17/2013 (MidnightTrader) -- Option implied volatility is mixed into the 2013 annual meeting of the American Society of Clinical Oncology (ASCO) from May 31 to June 4. AbbVie (ABBV) over all option implied volatility of 25 is ab...

    May 16, 2013

    Market Chatter: ARIAD Pharmaceuticals Down 7% As More Tools Allow Patients to Consider Skipping Treatments, Fox News Reports
    9:38AM ET on Thursday May 16, 2013 by Midnight Trader
    Companies Mentioned: ARIA
    09:38 AM EDT, 05/16/2013 (MidnightTrader) -- ARIAD Pharmaceuticals (ARIA) is down 7% just after the opening bell. A Fox News report says a growing number of tools are allowing many cancer patients to skip chemotherapy or other cancer treatments. ...

    May 15, 2013

    ARIAD Announces Data Presentations and Webcast of Investor Briefing at the 2013 ASCO Annual Meeting
    6:04PM ET on Wednesday May 15, 2013 by Business Wire
    Companies Mentioned: ARIA

    ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that clinical data on Iclusig(R) (ponatinib) and AP26113, its investigational inhibitor of anaplastic lymphoma kinase (ALK), epidermal growth factor receptor...

    New cancer tools allow patients to reconsider chemo
    5:59PM ET on Wednesday May 15, 2013 by Thomson Reuters
    Companies Mentioned: PFE, GHDX, ARIA

    By Deena Beasley

    LOS ANGELES, May 15 (Reuters) - After decades of using one-size-fits-all therapies to combat cancer, doctors are using new tools to he...

    May 14, 2013

    KERX, ARIA, PDLI added to BioStock Watch List at GSR
    9:33AM ET on Tuesday May 14, 2013 by Accesswire
    Companies Mentioned: KERX, PDLI, ACAD, ARIA

    New York, NY -- (ACCESSWIRE) -- 05/14/2013 -- Growing Stock Report initiates a Biotech Watch List adding Keryx Biopharmaceuticals Inc. (NASDAQ:KERX), Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), PDL BioPharma, Inc. (NASDAQ:PDLI), and ACADIA Pharm...

    May 13, 2013

    ARIAD to Present at UBS Global Healthcare Conference
    7:35AM ET on Monday May 13, 2013 by Business Wire
    Companies Mentioned: ARIA

    ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will present at the UBS Global Healthcare Conference being held in New York City. Harvey J. Berger, M.D., chairman and chief executive officer, will ...

    May 7, 2013

    Ariad Pharmaceuticals Climbs 5% - Posts Q1 Beat on Top and Bottom Lines; Reports First-Time Revenues for Iclusig
    10:27AM ET on Tuesday May 07, 2013 by Midnight Trader
    Companies Mentioned: ARIA
    10:27 AM EDT, 05/07/2013 (MidnightTrader) -- Ariad Pharmaceuticals (ARIA) is up 5.39% at $18.28 after the global oncology company reported a Q1 loss of $0.36 per share, narrower than the expected loss per share of $0.37, according to an analyst p...
    ARIAD Reports First Quarter 2013 Financial Results and Development Progress
    7:35AM ET on Tuesday May 07, 2013 by Business Wire
    Companies Mentioned: ARIA

    --Conference Call Scheduled Today at 8:30 a.m. ET

    ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today reported financial results for the first quarter, including revenue from its first cancer medicine, Iclusig(R) ...

    May 6, 2013

    ARIAD to Present at Bank of America Merrill Lynch Healthcare Conference
    7:35AM ET on Monday May 06, 2013 by Business Wire
    Companies Mentioned: ARIA

    ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will present at the Bank of America Merrill Lynch Healthcare Conference being held in Las Vegas. Harvey J. Berger, M.D., chairman and chief executive ...

    Apr 23, 2013

    MannKind, Ariad Pharma, Ziopharm Oncology, Galena Biopharma, and Novavax Under StockCall's Microscope
    8:19AM ET on Tuesday Apr 23, 2013 by PR Newswire
    Companies Mentioned: ZIOP, GALE, MNKD, NVAX, ARIA

    Following the expiration of patents on several blockbuster drugs, big pharma companies have been looking to boost their product pipeline. While in-house research and development will be crucial to boost product pipeline, major pharma companies ...

    ← Newer12Older →

    K=Thousands, M=Millions, B=Billions, TTM=Trailing 12 Month, MRQ=Most Recent Quarter, FYR=Fiscal Year End, NM=Not Meaningful, NA=Not Available

    GAAP = Generally Accepted Accounting Principles used in Financial Statements issued by the company, Non-GAAP = Adjusted Operating Earnings or Revenue used in comparison to Analyst Estimates. Adjustments are typically one-time gains or losses

    5:27 AM May 22, 2013
    Copyright ©2013 TD Waterhouse Canada Inc. All rights reserved.
    Privacy Policy | Internet Security | Legal
    Quotes, News, and Fundamentals provided by
    View restrictions
    News provided by